We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A Randomised-Controlled Trial of Vitamin D and Omega-3 Long Chain Polyunsaturated Fatty Acids in the Treatment of Core Symptoms of Autism Spectrum Disorder in Children.
- Authors
Mazahery, Hajar; Conlon, Cathryn A.; Beck, Kathryn L.; Mugridge, Owen; Kruger, Marlena C.; Stonehouse, Welma; Camargo, Carlos A.; Meyer, Barbara J.; Tsang, Bobby; Jones, Beatrix; von Hurst, Pamela R.
- Abstract
We evaluated the efficacy of vitamin D (VID), omega-3 long chain polyunsaturated fatty acids (omega-3 LCPUFA, OM), or both (VIDOM) on core symptoms of ASD. New Zealand children with ASD (n = 73; aged 2.5–8.0 years) received daily 2000 IU vitamin D3, 722 mg docosahexaenoic acid, both, or placebo. Outcome measures were Social Responsiveness Scale (SRS) and Sensory Processing Measure (SPM). Of 42 outcome measures comparisons (interventions vs. placebo), two showed greater improvements (P = 0.03, OM and VIDOM for SRS-social awareness) and four showed trends for greater improvements (P < 0.1, VIDOM for SRS-social communicative functioning, OM for SRS-total, VIDOM for SPM-taste/smell and OM for SPM-balance/motion). Omega-3 LCPUFA with and without vitamin D may improve some core symptoms of ASD but no definitive conclusions can be made.
- Subjects
NEW Zealand; TREATMENT of autism; THERAPEUTIC use of omega-3 fatty acids; THERAPEUTIC use of vitamin D; COMMUNICATIVE competence; SOCIAL skills; DOCOSAHEXAENOIC acid; CHOLECALCIFEROL; RANDOMIZED controlled trials; CHILDREN
- Publication
Journal of Autism & Developmental Disorders, 2019, Vol 49, Issue 5, p1778
- ISSN
0162-3257
- Publication type
Article
- DOI
10.1007/s10803-018-3860-y